Diclofenac metabolic pathway (WP2491)
Homo sapiens
CYP metabolism of the diclofenac drug (a NSAID), commonly used to treat pain and inflammatory diseases.
Authors
Egon Willighagen , Alex Pico , Denise Slenter , Friederike Ehrhart , and Eric WeitzActivity
Discuss this pathway
Check for ongoing discussions or start your own.
Cited In
Are you planning to include this pathway in your next publication? See How to Cite and add a link here to your paper once it's online.
Organisms
Homo sapiensCommunities
Annotations
Pathway Ontology
phase I biotransformation pathway via cytochrome P450 xenobiotic metabolic pathwayDisease Ontology
diseaseLabel | Type | Compact URI | Comment |
---|---|---|---|
diclofenac | Metabolite | pubchem.compound:3033 | |
3'-Hydroxydiclofenac | Metabolite | pubchem.compound:112230 | |
4'-hydroxydiclofenac | Metabolite | pubchem.compound:116545 | |
5-hydroxydiclofenac | Metabolite | pubchem.compound:3052566 | |
Metabolite | Metabolite | pubchem.compound:10065052 | |
4',5-Dihydroxydiclofenac | Metabolite | pubchem.compound:3052567 | |
CYP2C9 | Protein | uniprot:Q6IRV8 | |
CYP2B6 | Protein | uniprot:P20813 | |
CYP2C8 | Protein | uniprot:P10632 | |
CYP2C18 | Protein | uniprot:P33260 | |
CYP2C19 | Protein | uniprot:P33261 |
References
- Hepatic metabolism of diclofenac: role of human CYP in the minor oxidative pathways. Bort R, Macé K, Boobis A, Gómez-Lechón MJ, Pfeifer A, Castell J. Biochem Pharmacol. 1999 Sep 1;58(5):787–96. PubMed Europe PMC Scholia